Performance | Fosun Pharma's Profit Rose 22% Last Year

Fosun Pharma (02196) announced that its full-year attributable net profit to shareholders until the end of December 2025 was 3.371 billion yuan (RMB), an increase of 21.69% year-on-year, with earnings per share of 1.27 yuan; it also declared a final dividend of 0.39 yuan.

During the period, revenue was 41.498 billion yuan, up 1.44% year-on-year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin